Department of Oncology, University of Torino, School of Medicine, Torino, Italy; Laboratory of Cancer Genetics, Institute for Cancer Research at, Candiolo, Torino, Italy.
Int J Cancer. 2014 Mar 15;134(6):1289-99. doi: 10.1002/ijc.28464. Epub 2013 Sep 18.
The hepatocyte growth factor (HGF) also known as scatter factor activates cancer cell invasion and metastasis. We show that in ovarian cancer cells HGF induced the phosphorylation of the small heat shock protein of 27 kDa (HSP27) by activating the p38MAPK. HSP27 is increased in many cancers at advanced stage including ovarian cancer and associated with cancer resistance to therapy and poor patients' survival. The phosphorylation of HSP27 regulates both its chaperone activity and its control of cytoskeletal stability. We show that HSP27 was necessary for the remodeling of actin filaments induced by HGF and that motility in vitro depended on the p38MAPK-MK2 axis. In vivo, HSP27 silencing impaired the ability of the highly metastatic, HGF-secreting ovarian cancer cells to give rise to spontaneous metastases. This was due to defective motility across the vessel wall and reduced growth. Indeed, HSP27 silencing impaired the ability of circulating ovarian cancer cells to home to the lungs and to form experimental hematogenous metastases and the capability of cancer cells to grow as subcutaneous xenografts. Moreover, HSP27 suppression resulted in the sensitization of xenografts to low doses of the chemotherapeutic paclitaxel, likely because HSP27 protected microtubules from bundling caused by the drug. Altogether, these data show that the HSP27 is required for the proinvasive and prometastatic activity of HGF and suggest that HSP27 might be not only a marker of progression of ovarian cancer, but also a suitable target for therapy.
肝细胞生长因子 (HGF) 也被称为分散因子,可激活癌细胞的侵袭和转移。我们发现,在卵巢癌细胞中,HGF 通过激活 p38MAPK 诱导 27kDa 小分子热休克蛋白 (HSP27) 的磷酸化。HSP27 在许多癌症中都有增加,包括晚期卵巢癌,并与癌症对治疗的抵抗力和患者的不良预后相关。HSP27 的磷酸化调节其伴侣活性及其对细胞骨架稳定性的控制。我们发现 HSP27 对于 HGF 诱导的肌动蛋白丝重排是必需的,并且体外迁移依赖于 p38MAPK-MK2 轴。在体内,HSP27 沉默削弱了高转移性、分泌 HGF 的卵巢癌细胞产生自发性转移的能力。这是由于穿过血管壁的迁移缺陷和生长减少。事实上,HSP27 沉默削弱了循环卵巢癌细胞归巢到肺部并形成实验性血源性转移的能力,以及癌细胞作为皮下异种移植物生长的能力。此外,HSP27 抑制导致异种移植物对低剂量化疗药物紫杉醇的敏感性增加,可能是因为 HSP27 保护微管免受药物引起的束状。总之,这些数据表明 HSP27 是 HGF 促进侵袭和转移活性所必需的,并表明 HSP27 可能不仅是卵巢癌进展的标志物,也是治疗的合适靶点。